JP2003521916A5 - - Google Patents

Download PDF

Info

Publication number
JP2003521916A5
JP2003521916A5 JP2001557921A JP2001557921A JP2003521916A5 JP 2003521916 A5 JP2003521916 A5 JP 2003521916A5 JP 2001557921 A JP2001557921 A JP 2001557921A JP 2001557921 A JP2001557921 A JP 2001557921A JP 2003521916 A5 JP2003521916 A5 JP 2003521916A5
Authority
JP
Japan
Prior art keywords
antibody
ige
dog
described method
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001557921A
Other languages
English (en)
Japanese (ja)
Other versions
JP4605973B2 (ja
JP2003521916A (ja
Filing date
Publication date
Priority claimed from US09/592,998 external-priority patent/US6504013B1/en
Application filed filed Critical
Publication of JP2003521916A publication Critical patent/JP2003521916A/ja
Publication of JP2003521916A5 publication Critical patent/JP2003521916A5/ja
Application granted granted Critical
Publication of JP4605973B2 publication Critical patent/JP4605973B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001557921A 2000-02-01 2001-01-30 イヌのアレルギー治療用の組換えキメラ抗−IgEモノクローナル抗体 Expired - Fee Related JP4605973B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17962900P 2000-02-01 2000-02-01
US60/179,629 2000-02-01
US09/592,998 2000-06-12
US09/592,998 US6504013B1 (en) 2000-02-01 2000-06-12 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
PCT/US2001/002924 WO2001057090A1 (en) 2000-02-01 2001-01-30 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody

Publications (3)

Publication Number Publication Date
JP2003521916A JP2003521916A (ja) 2003-07-22
JP2003521916A5 true JP2003521916A5 (cg-RX-API-DMAC7.html) 2008-03-27
JP4605973B2 JP4605973B2 (ja) 2011-01-05

Family

ID=26875491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557921A Expired - Fee Related JP4605973B2 (ja) 2000-02-01 2001-01-30 イヌのアレルギー治療用の組換えキメラ抗−IgEモノクローナル抗体

Country Status (6)

Country Link
US (1) US6504013B1 (cg-RX-API-DMAC7.html)
EP (1) EP1254180B1 (cg-RX-API-DMAC7.html)
JP (1) JP4605973B2 (cg-RX-API-DMAC7.html)
AU (1) AU2001233102A1 (cg-RX-API-DMAC7.html)
DE (1) DE60127237T2 (cg-RX-API-DMAC7.html)
WO (1) WO2001057090A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393529B2 (en) * 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
CA2429372A1 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
CA2469833C (en) * 2001-12-21 2008-05-20 Idexx Laboratories, Inc. Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
NZ540194A (en) * 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
US20060034845A1 (en) * 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
US20100003253A1 (en) * 2002-11-08 2010-01-07 Ablynx N.V. Single domain antibodies directed against epidermal growth factor receptor and uses therefor
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
US7632687B2 (en) * 2004-03-23 2009-12-15 Quidel Corporation Hybrid phase lateral flow assay
ATE524561T1 (de) * 2004-04-06 2011-09-15 Sinai School Medicine Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
JP2006151880A (ja) * 2004-11-30 2006-06-15 Asahi Breweries Ltd 抗イヌIgEモノクローナル抗体、その製造法および用途
BRPI0608584B8 (pt) 2005-03-11 2021-05-25 Wyeth Corp métodos de recuperar um produto purificado
JP2007172129A (ja) * 2005-12-20 2007-07-05 Sony Corp 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
ES2635870T3 (es) * 2007-07-09 2017-10-05 Nestec S.A. Métodos para reducir las alergias provocadas por alérgenos ambientales
ES2665954T3 (es) 2010-08-19 2018-04-30 Zoetis Belgium S.A. Anticuerpos anti-NGF y su uso
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6199054B2 (ja) * 2013-03-19 2017-09-20 公益財団法人かずさDna研究所 抗イヌIgEモノクローナル抗体並びに抗イヌIgEモノクローナル抗体の重鎖可変領域及び軽鎖可変領域
JP7127859B2 (ja) * 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
CN109143137B (zh) * 2018-06-14 2020-09-29 国电南瑞科技股份有限公司 一种发电机pmu装置测量精度提升方法
WO2021195560A1 (en) * 2020-03-27 2021-09-30 Aquavit Pharmaceuticals, Inc, Methods of detecting allergic reactions in subjects using microchannel delivery devices

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422258A (en) 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
EP0617127A1 (en) 1987-12-31 1994-09-28 Tanox Biosystems, Inc. Antigenic epitopes on B cell-bound IgE Immunoglobulins
JP2837240B2 (ja) * 1990-06-07 1998-12-14 財団法人化学及血清療法研究所 イヌ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
JP2811096B2 (ja) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 イヌ免疫グロブリンκ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
JP2811089B2 (ja) * 1989-08-25 1998-10-15 財団法人化学及血清療法研究所 イヌ×マウスヘテロハイブリドーマおよびイヌ免疫グロブリンλ鎖の定常領域をコードする遺伝子断片
EP1260521B1 (en) * 1991-08-14 2007-11-21 Genentech Inc. Immunoglobulin variants for specific Fc epsilon receptors
US5965709A (en) 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
SE9102808L (sv) 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
ATE228536T1 (de) 1993-03-11 2002-12-15 Tanox Biosystems Inc Antigene epitope von ige repräsentierenden peptiden auf der b-zell-oberfläche aber nicht auf oberflächen von basophilen
US5629415A (en) 1994-11-09 1997-05-13 Merck & Co., Inc. DNA encoding canine immunoglobulin E
AU1146897A (en) 1995-12-08 1997-06-27 Idexx Laboratories, Inc. Methods and compositions concerning allergy in dogs
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
ES2234180T3 (es) 1998-04-09 2005-06-16 Idexx Laboratories, Inc. Proteinas de fijacion especifica para el tratamiento de la alergia canina.
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Similar Documents

Publication Publication Date Title
Andersen et al. Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages
ATE454124T1 (de) Rekombinante anti-cd30-antikörper und deren verwendungen
Gevaert et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue
DK0930365T3 (da) Bindingsdomæner i Serrate-protein
AU2019312565B2 (en) Anti-MICA/B antibodies that block MICA/B shedding and methods of use
WO2005000244A3 (en) Methods and compositions for treating rheumatoid arthritis
KR960704576A (ko) CD40에 대한 항체(Antibodies to CD40)
JP2004517611A5 (cg-RX-API-DMAC7.html)
RU2012133522A (ru) Новое применение соединений ил-1 бета
NO20051048L (no) Terapeutisk humant anti-IL-1R1 monoklonalt antistoff
RU2007139452A (ru) СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ МОДУЛИРОВАНИЯ ГИПЕРСТАБИЛИЗИРОВАННОГО c-met
JP2004510752A5 (cg-RX-API-DMAC7.html)
DE69334266D1 (de) Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate
NZ712762A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
AU9399501A (en) Therapeutic antibodies
CA2624935A1 (en) Anti-myostatin antibodies
JP2018529635A5 (cg-RX-API-DMAC7.html)
CA2417432A1 (en) Modified polypeptides stabilized in a desired conformation and methods for producing same
RU2018100129A (ru) Способы лечения подагры
Seppälä et al. Mouse Ig coded by VH families S107 or J606 bind to protein A.
Rice et al. Cross-reactivity of monoclonal antibodies against peptide 277–294 of rainbow trout CYP1A1 with hepatic CYP1A among fish
AU6819600A (en) Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
JP2002538771A5 (cg-RX-API-DMAC7.html)
JP2025087764A5 (cg-RX-API-DMAC7.html)
Chenoweth et al. Mutation of the TGN1412 anti‐CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super‐agonist activity